MCMANUS MICHAEL A JR

Average Profitability
12.15%
Insider Buys Quantity
10
Insider Buys Sum
$709,344.55
Insider Sells Quantity
3
Insider Sells Sum
$3.25M

Insider Activity of MCMANUS MICHAEL A JR

According to the SEC Form 4 filings, MCMANUS MICHAEL A JR, being in a position of

  1. director at United States Antimony Corporation,
    оver the last 12 months, has bought 255000 shares for $182,015, and sold 0 shares,
    over all time since 2024-08-14, has bought 255000 shares for $182,015, and sold 0 shares.

The largest purchase of all time was on 2017-05-19 and amounted to 10000 shares of The Eastern Company for $259,000.

The largest sale of all time was on 2020-08-18 and amounted to 16000 shares of Novavax, Inc. for $2.34M.

Biography of MCMANUS MICHAEL A JR

No biography is available at this moment.

2024-12-10PurchaseUnited States Antimony Corporation
UAMY
director
70,000
0.067%
$1.46$102,060+38.13%
2024-11-18PurchaseUnited States Antimony Corporation
UAMY
director
50,000
0.0457%
$0.56$28,250+20.35%
2024-08-14PurchaseUnited States Antimony Corporation
UAMY
director
135,000
0.1285%
$0.38$51,7050%
2021-03-19SaleNovavax, Inc.
NVAX
director
4,000
0.0053%
$220.78$883,110-21.79%
2020-08-18SaleNovavax, Inc.
NVAX
director
16,000
0.026%
$146.00$2.34M+3.14%
2019-11-18SaleNovavax, Inc.
NVAX
director
7,858
0.0325%
$3.82$30,029+1,069.45%
2017-05-19PurchaseThe Eastern Company
EML
director
10,000
0.1429%
$25.90$259,000-1.43%
2017-05-12PurchaseNovavax, Inc.
NVAX
director
40,000
0.0137%
$0.97$38,792+19%
2017-05-11PurchaseNovavax, Inc.
NVAX
director
20,000
0.0064%
$0.84$16,800+27.96%
2016-09-21PurchaseNovavax, Inc.
NVAX
director
60,000
0.0184%
$1.61$96,594-34.54%
2008-07-31PurchaseNovavax, Inc.
NVAX
director
17,590
0.0299%
$2.85$50,044-19.84%
2005-09-01PurchaseNovavax, Inc.
NVAX
director
20,000
0.0508%
$1.60$32,000+192.07%
2004-08-16PurchaseNovavax, Inc.
NVAX
director
10,000
0.0265%
$3.41$34,100-30.33%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.